Ligand Pharmaceuticals Given New 135.00 Price Target at Benchmark
| NMSAX Fund | USD 27.29 0.25 0.91% |
Slightly above 61% of Columbia Small's investor base is looking to short. The analysis of overall sentiment of trading Columbia Small Cap mutual fund suggests that many investors are alarmed at this time. Columbia Small's investing sentiment can be driven by a variety of factors including economic data, Columbia Small's earnings reports, geopolitical events, and overall market trends.
Columbia |
Ligand Pharmaceuticals had its price objective lifted by stock analysts at Benchmark from 110.00 to 135.00 in a research note issued to investors on Friday,Benzinga reports. The firm presently has a buy rating on the biotechnology companys stock. Benchmarks price objective would suggest a potential upside of 12.33 percent from the
Read at thelincolnianonline.com
 |
Columbia Small Fundamental Analysis
We analyze Columbia Small's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Columbia Small using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Columbia Small based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Columbia Small is currently under evaluation in price to book among similar funds. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Columbia Small Cap Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Columbia Small mutual fund to make a market-neutral strategy. Peer analysis of Columbia Small could also be used in its relative valuation, which is a method of valuing Columbia Small by comparing valuation metrics with similar companies.
Peers
Columbia Small Related Equities
| VFAIX | Vanguard Financials | 0.03 | ||||
| IAAEX | Transamerica Financial | 0.40 | ||||
| BTO | John Hancock | 0.46 | ||||
| MSVIX | Mesirow Financial | 0.55 | ||||
| SBFAX | 1919 Financial | 0.76 | ||||
| GCFSX | Gabelli Global | 2.35 |
Other Information on Investing in Columbia Mutual Fund
Columbia Small financial ratios help investors to determine whether Columbia Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Columbia with respect to the benefits of owning Columbia Small security.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |